BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10726363)

  • 21. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Storey RF; May JA; Heptinstall S
    Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.
    Basic-Micic M; Breddin HK
    Semin Thromb Hemost; 1993; 19 Suppl 1():22-8. PubMed ID: 8395725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet aggregation in different antithrombotic regimens. Possible proaggregant effect of low level oral anticoagulation.
    Perez Gomez F; Lourenzo PI; Companion J; Escriba A; Perez Saldaña D; Guillén M; Vargas E; S-Harguindey L
    Rev Port Cardiol; 2002 May; 21(5):541-51. PubMed ID: 12174518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet function in dogs with congenital portosystemic shunt.
    Kalbantner K; Meyer-Lindenberg A; Mischke R
    Vet J; 2011 May; 188(2):189-92. PubMed ID: 20580889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of platelets with standard heparin and low molecular weight fractions.
    Dunn FW; Soria C; Thomaidis A; Soria J; Dupuy E; Bellucci S; Tobelem G
    Nouv Rev Fr Hematol (1978); 1984; 26(4):249-53. PubMed ID: 6089103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo anticoagulant and antiplatelet effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H.
    Bagdy D; Barabás E; Szabó G; Bajusz S; Széll E
    Thromb Haemost; 1992 Mar; 67(3):357-65. PubMed ID: 1641827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
    Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
    Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment.
    Arends JP; Krediet RT; Boeschoten EW; van der Lelie J; Veenhof CH; von dem Borne AE
    Proc Eur Dial Transplant Assoc; 1981; 18():280-5. PubMed ID: 7329972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preclinical studies for the use of the platelet function analyser PFA-100 with the collagen/ADP cartridge in dogs].
    Mischke R; Keidel A
    Dtsch Tierarztl Wochenschr; 2002 May; 109(5):235-8. PubMed ID: 12073497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
    Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
    Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced platelet reactivity in heartworm-infected dogs.
    Boudreaux MK; Dillon AR; Spano JS
    Am J Vet Res; 1989 Sep; 50(9):1544-7. PubMed ID: 2802330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs.
    Johnson GJ; Rao GH; White JG
    Am J Pathol; 1978 Apr; 91(1):85-106. PubMed ID: 645824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oral pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists.
    Sermet A; Aybak M; Ulak G; Güzel C; Denli O
    Arzneimittelforschung; 1995 Jan; 45(1):19-21. PubMed ID: 7893263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effect of ethanol on ADP and collagen-induced platelet aggregation.
    Bengmark S; Elmér O; Göransson G; Zoucas E
    Thromb Haemost; 1981 Dec; 46(4):673-5. PubMed ID: 7330816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelets of patients with peripheral arterial disease demonstrate a hypersensitive response to heparin.
    Reininger CB; Greinacher A; Eibl-Eibesfeldt B; Lasser R; Steckmeier B; Schweiberer L
    Int Angiol; 1996 Sep; 15(3):207-14. PubMed ID: 8971577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood.
    Zhang QH; Das K; Siddiqui S; Myers AK
    Alcohol Clin Exp Res; 2000 Apr; 24(4):528-34. PubMed ID: 10798590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever.
    Szczeklik A; Milner PC; Birch J; Watkins J; Martin JF
    Thromb Haemost; 1986 Dec; 56(3):283-7. PubMed ID: 3563961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.